Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ulrika Warpman Berglund
Cancer-Specific Synthetic Lethality Between ATR and CHK1 Kinase Activities
Cell Reports
Biochemistry
Genetics
Molecular Biology
Hypoxic Signaling and the Cellular Redox Tumor Environment Determine Sensitivity to MTH1 Inhibition
Cancer Research
Cancer Research
Oncology
Related publications
ATR and DNA-PK/CHK1 Elicit Distinct Responses in Cancer Cells
Cancer Discovery
Oncology
Ranking Differential Drug Activities From Dose-Response Synthetic Lethality Screens
Journal of Biomolecular Screening
Molecular Medicine
Pharmacology
Biochemistry
Analytical Chemistry
Biotechnology
Drug Discovery
E-Cadherin/Ros1 Inhibitor Synthetic Lethality in Breast Cancer
Cancer Discovery
Oncology
Immunotherapy Exposes Cancer Stem Cell Resistance and a New Synthetic Lethality
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Synthetic Lethality as a Targeted Approach to Advanced Prostate Cancer
Phosphatase Type 2a-Dependent and -Independent Pathways for ATR Phosphorylation of Chk1
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Kinase- And Rapsyn-Independent Activities of the Muscle-Specific Kinase (MuSK)
Neuroscience
Neuroscience
KEAP1-Dependent Synthetic Lethality Induced by AKT and TXNRD1 Inhibitors in Lung Cancer
Cancer Research
Cancer Research
Oncology
Polo-Like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
Clinical Cancer Research
Cancer Research
Oncology